Read the full paper here: As new synthetic opioids continue to emerge in an evolving drug landscape, diagnostic tools must keep up with growing trends and changes in the drug supply
On 7 April, the FDA published several warning letters, including a batch to companies that the agency said are marketing GLP-1 products, dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) products, and triple agonist (GLP-1/GIP/glucagon) products without regulatory approval
Although the most commonly reported adverse events were gastrointestinal side effects such as nausea, vomiting, and diarrhoea, the treatment was well tolerated in the study population [59, 60]
a special section for students, CEOs and high performers
Diabetes Care 2019 Sep
When combined with a balanced lifestyle, L-Carnitine can help you feel more energised, support fat loss and improve exercise performance so your fitness journey becomes more fulfilling and sustainable